First Response Healthcare

firstresponse.ae

First Response Healthcare is a proficient and world-class home healthcare company committed to providing patient-centred, high-quality and comprehensive health care services across the Middle- East Region. Our focus is to provide prompt and reliable medical care to our patients with the help of a team of highly competent and certified doctors, nurses, physiotherapists and medical experts backed with years of experience.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Pharmacy Market

EIRION THERAPEUTICS ANNOUNCES STRATEGIC AGREEMENT FOR HTL BIOTECHNOLOGY TO BECOME EIRION'S EXCLUSIVE BOTULINUM API MANUFACTURER

Eirion Therapeutics, Inc. | September 09, 2021

news image

Eirion Therapeutics, Inc., an aesthetic dermatology company headquartered in Woburn, Massachusetts, announced that HTL Biotechnology, the worldwide leader in biotechnology solutions using hyaluronic acid and other biopolymers, will become Eirion's exclusive botulinum active pharmaceutical ingredient (API) manufacturer. Botulinum is the active ingredient in Eirion's lead product candidate ET-01, a topical neuromodulator being developed for Crow's Feet wrinkles and prima...

Read More

PHARMACY MARKET

BIOFOURMIS ACCELERATES AND SIMPLIFIES DRUG DEVELOPMENT WITH EXPANDED DIGITAL CLINICAL TRIALS SOLUTION

PR Newswire | September 21, 2023

news image

Biofourmis, a leading global technology-enabled care delivery company, announced today the release of its expanded Digital Clinical Trials solution within the Biofourmis platform for biopharma and other life sciences companies. The solution offers robust digital tools and resources for trial sponsors and investigators aimed at accelerating drug development and improving access and diversity wh...

Read More

PREMIER INC. SUPPORTS FDA, DEA REFORMS AND REGULATORY WAIVERS TO COUNTER DRUG SHORTAGES

Premier Inc. | July 24, 2020

news image

Premier Inc. today provided the U.S. Food and Drug Administration (FDA) and the U.S. Drug Enforcement Administration (DEA) with a list of reforms and regulatory waivers that the company believes should be extended beyond the COVID-19 pandemic and made permanent thereafter in order to prevent drug shortages. “During the height of the COVID-19 pandemic, we saw demand for many common pharmaceuticals surge by an average of more than 150 percent,” said Blair Childs, Premier...

Read More

Business Insights

CATO SMS ACQUIRES NUVENTRA IN ORDER TO EXPAND ITS DRUG DEVELOPMENT OFFERING INTO CLINICAL PHARMACOLOGY

Nuventra, CATO SMS | May 27, 2021

news image

CATO SMS, a global provider of regulatory and clinical research services, announced today the acquisition of Nuventra, Inc., to expand its offering into the critical area of clinical pharmacology. Nuventra, headquartered in Durham, North Carolina, is a leading company in clinical pharmacology science and services. The acquisition expands CATO SMS's portfolio of specialized solutions that help biopharmaceutical companies with drug development by providing a key set of skills targeted at signi...

Read More
news image

Pharmacy Market

EIRION THERAPEUTICS ANNOUNCES STRATEGIC AGREEMENT FOR HTL BIOTECHNOLOGY TO BECOME EIRION'S EXCLUSIVE BOTULINUM API MANUFACTURER

Eirion Therapeutics, Inc. | September 09, 2021

Eirion Therapeutics, Inc., an aesthetic dermatology company headquartered in Woburn, Massachusetts, announced that HTL Biotechnology, the worldwide leader in biotechnology solutions using hyaluronic acid and other biopolymers, will become Eirion's exclusive botulinum active pharmaceutical ingredient (API) manufacturer. Botulinum is the active ingredient in Eirion's lead product candidate ET-01, a topical neuromodulator being developed for Crow's Feet wrinkles and prima...

Read More
news image

PHARMACY MARKET

BIOFOURMIS ACCELERATES AND SIMPLIFIES DRUG DEVELOPMENT WITH EXPANDED DIGITAL CLINICAL TRIALS SOLUTION

PR Newswire | September 21, 2023

Biofourmis, a leading global technology-enabled care delivery company, announced today the release of its expanded Digital Clinical Trials solution within the Biofourmis platform for biopharma and other life sciences companies. The solution offers robust digital tools and resources for trial sponsors and investigators aimed at accelerating drug development and improving access and diversity wh...

Read More
news image

PREMIER INC. SUPPORTS FDA, DEA REFORMS AND REGULATORY WAIVERS TO COUNTER DRUG SHORTAGES

Premier Inc. | July 24, 2020

Premier Inc. today provided the U.S. Food and Drug Administration (FDA) and the U.S. Drug Enforcement Administration (DEA) with a list of reforms and regulatory waivers that the company believes should be extended beyond the COVID-19 pandemic and made permanent thereafter in order to prevent drug shortages. “During the height of the COVID-19 pandemic, we saw demand for many common pharmaceuticals surge by an average of more than 150 percent,” said Blair Childs, Premier...

Read More
news image

Business Insights

CATO SMS ACQUIRES NUVENTRA IN ORDER TO EXPAND ITS DRUG DEVELOPMENT OFFERING INTO CLINICAL PHARMACOLOGY

Nuventra, CATO SMS | May 27, 2021

CATO SMS, a global provider of regulatory and clinical research services, announced today the acquisition of Nuventra, Inc., to expand its offering into the critical area of clinical pharmacology. Nuventra, headquartered in Durham, North Carolina, is a leading company in clinical pharmacology science and services. The acquisition expands CATO SMS's portfolio of specialized solutions that help biopharmaceutical companies with drug development by providing a key set of skills targeted at signi...

Read More